Navigation Links
Bledsoe Lo-Top Boot

ProductsBledsoe Lo-Top Boot
Company Bledsoe Brace Systems
Item Bledsoe Lo-Top Boot
Features 
  • Aluminum boot shell and upright system that, unlike plastic boots, can be reformed to fit virtually any leg or ankle shape
  • Low profile rocker bottom helps eliminate pelvic tilt and alleviate low back pain
  • Fast, easy fitting saves time over complicated casting procedures
  • Unique rocker design allows patients to closely simulate a near normal gait without abnormal loads on any joints
  • Contains 2 layers of pads that contour to the ankle shape and support the ankle for total control
  • Ultra-breathable foam wrap for maximum comfort
  • Description The Bledsoe Lo-Top Boot is designed as a flexible and attractive alternative to casting for the mid-tibia or fibula to mid-foot area and also for second and third degree ankle sprains. The Lo-Top is 2" shorter than the Bledsoe Hi-Top Boot but offers similar support. The Bledsoe EZ Set Lo-Top Boot is designed for range of motion from 20 degrees of dorsi-flexion to 40 degrees of plantar-flexion in 10 degree increments.
    Info Bledsoe Brace Systems
    Customer Service: (888) 253-3763
    Web site: http://www.bledsoebrace.com/

    Related medicine products :

    1. Bledsoe Achilles Boot
    2. Bledsoe Breeze Boot
    3. Bledsoe Conformer Boot
    4. Bledsoe Flatform Boot
    5. Bledsoe Hi-Top Boot
    6. Bledsoe Low Cost Boot
    7. Bledsoe Mid-Calf Boot
    8. Bledsoe Short Term Boot
    9. Bledsoe PTB Boot
    10. Bledsoe Tenderfoot Boot
    11. Bledsoe M-Brace Ankle Support
    Straight shafts with heavy Elschnig teeth. Flat serrated handle with slide style lock and polished finished....
    Straight shafts with fine Pierse type tips. Flat smooth handle with dull finish....
    Straight shafts with 1 x 2 Elsching style teeth. Wide serrated handle with polished finish....
    Straight crisscross serrated tips. Flat handle with holes and polished finish....
    Medicine Products:
    (Date:7/6/2015)... ... July 06, 2015 , ... ... year for aesthetic reasons, which is why liposuction regularly ranks among the top ... however, fat reduction has become more than a way to slim down a ...
    (Date:7/6/2015)... ... July 06, 2015 , ... ... California, has partnered with Woodbridge Walk-In Urgent Care to offer on-site health screenings. ... serious medical conditions. Screenings are affordable and accurate and run about an hour ...
    (Date:7/6/2015)... ... July 06, 2015 , ... MD Now, the leading and fastest-growing urgent care ... urgent care center will serve residents and visitors in the Cutler Bay area, giving ... 22nd South Florida location, the new facility will be the fourth to serve Miami-Dade ...
    (Date:7/6/2015)... ... July 06, 2015 , ... Dr. Lawrence Green is now offering ... Kybella is a non-surgical method to dissolve fat cells and is the ... severe fat deposits under the chin, commonly known as a double chin. Dr. Green ...
    (Date:7/6/2015)... ... July 06, 2015 , ... The Path of Least Resistance: The Evolution of ... with the U.S. economy over the past 40 years. The book explores the evolution ... ways, the book is a time capsule that chronicles the economic development of the ...
    Breaking Medicine News(10 mins):Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 2Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 3Health News:Woodbridge Walk-In Offers Affordable Early Detection Health Screenings Through Longevity 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 3Health News:Rockville, MD Practice Now Offering New FDA-Approved Non-Surgical Double Chin Treatment 2Health News:New Book Brings Reveals The Repercussions Associated With The Global Economy 2
    ... PRINCETON, N.J., Aug. 24 Ranbaxy Pharmaceuticals Inc. (RPI), ... today that RLL has received approval from the U.S. Food ... 1 mg and 2 mg. The Office of Generic ... formulations to be bioequivalent and have the same therapeutic effect ...
    ... , , ATLANTA, Aug. 24 ... by the American Diabetes Association (ADA), kicks off in Atlanta on ... F earless A frican-Americans C onnected and E ... also supported by Aetna, educates and empowers African-Americans living with diabetes ...
    ... , , SKILLMAN, N.J., Aug. ... community and hospital care, today announced new data showing that AQUACEL(R) ... an MRI environment. , , AQUACEL(R) Ag dressing ... gelling benefits of ConvaTec,s proprietary Hydrofiber(R) Technology plus the ...
    ... International Journal of Obesity reports that consumption of ... a key aspect of successful weight maintenance. ... intake, as well as the dietary restraint of over ... use of artificially sweetened beverages may be an important ...
    ... enough, experts warn , MONDAY, Aug. 24 (HealthDay News) -- ... virus if they believe the risks outweigh the benefits, suggests ... in Vancouver before the start of the current swine flu ... a new vaccine in the event of a pandemic. , ...
    ... , SAN ANTONIO, Aug. 24 Fall 2009 ... family schedules, which can have a devastating impact on family pets that ... PurinaCare(R) Pet Health Insurance ( www.purinacare.com ), which is committed to help ... all pet owners to be aware of the signs of post-summer ...
    Cached Medicine News:Health News:Ranbaxy Receives Final Approval to Manufacture and Market Glycopyrrolate Tablets 2Health News:Grammy(R)-Nominated R&B Sensation Angie Stone Teams up With the American Diabetes Association to Encourage African-Americans to be Victorious in the Face of Diabetes 2Health News:Grammy(R)-Nominated R&B Sensation Angie Stone Teams up With the American Diabetes Association to Encourage African-Americans to be Victorious in the Face of Diabetes 3Health News:Grammy(R)-Nominated R&B Sensation Angie Stone Teams up With the American Diabetes Association to Encourage African-Americans to be Victorious in the Face of Diabetes 4Health News:New Data Demonstrate Magnetic Resonance Safety of AQUACEL(R) Ag Dressing 2Health News:New Data Demonstrate Magnetic Resonance Safety of AQUACEL(R) Ag Dressing 3Health News:New Data Demonstrate Magnetic Resonance Safety of AQUACEL(R) Ag Dressing 4Health News:New research: Consumption of sugar substitutes assists in long-term weight control 2Health News:Not Everyone Wants to Be Vaccinated Against Pandemic Flu 2Health News:Does Your Pet Have Post-Summer Separation Anxiety? 2Health News:Does Your Pet Have Post-Summer Separation Anxiety? 3
    (Date:7/6/2015)... , July 6, 2015 Array BioPharma,s ... showcased this past weekend at the 2015 ESMO ... presentation.  At the meeting, data were shared from ... a 100-patient randomized Phase 2 expansion of that ... an EGFR inhibitor, with or without the addition ...
    (Date:7/6/2015)... BOSTON , July 6, 2015 ... Inc. (NASDAQ: ISIS ), announced today that ... Orphan Drug Designation to volanesorsen (ISIS-APOCIII Rx ) ... Syndrome (FCS).  FCS is a rare genetic disease ... of pancreatitis. In a Phase 2 study published ...
    (Date:7/4/2015)... Añadir micro esferas de ... línea para pacientes con cáncer colorrectal metastásico no ... libre de progresión en ese órgano ... (mCRC) que se ha propagado sólo al hígado ... de progresión (PFS) en el hígado desde la ...
    Breaking Medicine Technology:Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 2Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 3Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 4Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 2Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 3Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 4Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 5Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 6El Congreso Mundial del Cáncer Gastrointestinal presenta nuevos datos del estudio SIRFLOX 2El Congreso Mundial del Cáncer Gastrointestinal presenta nuevos datos del estudio SIRFLOX 3El Congreso Mundial del Cáncer Gastrointestinal presenta nuevos datos del estudio SIRFLOX 4El Congreso Mundial del Cáncer Gastrointestinal presenta nuevos datos del estudio SIRFLOX 5